Want to create an interactive transcript for this episode?
Podcast: Once Upon A Gene
Episode: David Solomon - CEO of Pharnext - A Biopharmaceutical Company
Description: Dr. David Solomon is the CEO of Pharnext, an advanced clinical-stage biopharmaceutical company using artificial intelligence to create therapies for rare and orphan diseases. Their first drug for Charcot-Marie-Tooth Disease (CMT1A) is in it's second pivotal Phase 3 trial. CMT1A is a rare genetic disorder of the nervous system with no current satisfactory treatment available. Dr. Solomon is committed to moving Pharnext's work on the CMT1A drug forward to bring solutions to the patients and families affected by the disease.EPISODE HIGHLIGHTSShare some background on your career and Pharnext.<...